Search Report
Home   About Us   Press Room   Custom Research   Research Store   Contact Us
Press Releases

 

Cost to Drive Indian Clinical Trial Market

Oct 29, 2009
Share |
 

India is likely to become one of the biggest destinations for clinical research outsourcing. Pioneer clinical research companies worldwide have realized that outsourcing their projects in India will be more beneficial than other countries since India has a vast pool of patients suffering from various chronic diseases like cancer, diabetes and HIV, and require low investments. As per a new research report "Booming Clinical Trials Market in India" by RNCOS, it is estimated that the clinical trial market in India is anticipated to grow at a CAGR of around 30% from 2010 to 2012.

Our industry analysis finds that there are various market trends like clinical data management and In Vitro diagnostic market that have reported strong growth in line with the developments occurred within the Indian clinical trial market. Each of these market trends have been extensively covered in the report. Besides, the new research has done a comprehensive research on the overall clinical trial market in India, with focus on present and future trends to enable clients understand the market dynamics.

"With the rising prevalence of chronic diseases and excellent medical infrastructure, the country has become a prime location for pharma companies to conduct clinical trials at low cost", says an Analyst at RNCOS.

The report also provides an in-depth analysis of the factors driving growth in the industry and explains the importance of these factors for the industry development in coming years. Our research study includes complete demographic information of patients and medical infrastructure in the country.

"Booming Clinical Trials Market in India" provides an overview of the regulatory environment and steps taken by the government to support the industry growth. The research study also gives complete details of key players operating in the market along with their business information and area of expertise. This will provide our clients an additional edge over their competitors while devising business strategies.

For more information visit: http://www.rncos.com/Report/IM564.htm


Related Press Releases:
» US Generic Drugs to Grow Strongly in Future
» FDI Fuelling Growth of Hospital Services in India
» Indian Diagnostic Market Poised to Grow at 16% CAGR
» Next-Generation Sequencing Market to Touch US$ 2 Billion-Mark by 2015
» European Regenerative Medicine Market worth US$ 2.2 Billion in 2010
 
Related Research Reports
Related Research News
May 03, 2010
New Product Launches Led US Pharma Market to Grow Strongly in 2009
Apr 30, 2010
India to be Among Top 10 Drug Producers by 2020
Apr 05, 2010
China ? On the Way to Become Third Largest Pharma Market
Jan 25, 2010
Indian Government to Set Up Special Zones to Boost Pharma Exports
Phone : +91 (120) 4224700/01/02/03
Fax : +91 (120) 4224707

Copyright © 2011, RNCOS, 2002-2011

Home
About Us
Careers
Request a Quote
Discounted Reports
Contact Us
Add URL
FAQ
Upcoming Reports